RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Retinoblastoma: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Between Scylla and Charybdis: Weighing Salvage and Loss in Retinoblastoma.
Berry Jesse L, Ophthalmology (17 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42891668/
- 2.
Effectiveness and safety of cataract surgery in eyes treated for retinoblastoma in the past. - A cohort study
Ramah Ibrahim Nazer et al., Research Square (14 October 2026)
https://doi.org/10.21203/rs.3.rs-10839436/v1
- 3.
Multi-institutional study evaluating the role of liquid biopsy to determine risk of extraocular disease, therapy response and recurrence in retinoblastoma.
Farouk Sait Sameer et al., Clinical cancer research : an official journal of the American Association for Cancer Research (14 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42873577/
- 4.
Trust in Retinoblastoma Care: Understanding Parent-Physician Relationships in Collectivist, Low-Resource Settings.
Namjoshi Shraddha et al., Pediatric blood & cancer (13 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42867058/
- 5.
[The Role of Intravitreal Chemotherapy in the Treatment of Retinoblastoma].
Rastoaca Cristina et al., Klinische Monatsblatter fur Augenheilkunde (13 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42869096/
Clinical Trials : Australian Sites
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
NCT05504291 · Recruiting · Phase 2 · Children's Oncology Group
Up to age 18
https://clinicaltrials.gov/study/NCT05504291
- 2.
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
NCT00831844 · Completed · Phase 2 · National Cancer Institute (NCI)
Ages 7 Months to 30
https://clinicaltrials.gov/study/NCT00831844
- 3.
Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
NCT00554788 · Completed · Phase 3 · Children's Oncology Group
Up to age 10
https://clinicaltrials.gov/study/NCT00554788
- 4.
Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma
NCT00335738 · Completed · Phase 3 · Children's Oncology Group
Up to age 6
https://clinicaltrials.gov/study/NCT00335738
- 5.
Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
NCT00006102 · Completed · Phase 2 · National Cancer Institute (NCI)
Up to age 21
https://clinicaltrials.gov/study/NCT00006102
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Retinoblastoma
Retinoblastoma is a rare cancer of the retina, the light-sensing layer at the back of the eye, and it almost always begins in early childhood. It may affect one or both eyes and can be inherited through a change in the RB1 gene. Signs include a white pupil reflex or a turned eye. Treatment may involve chemotherapy, laser or freezing therapy, and sometimes surgery, with long-term eye and cancer follow-up.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Retinoblastoma?
Retinoblastoma is a rare cancer of the retina, the light-sensing layer at the back of the eye, and it almost always begins in early childhood. It may affect one or both eyes and can be inherited through a change in the RB1 gene. Signs include a white pupil reflex or a turned eye. Treatment may involve chemotherapy, laser or freezing therapy, and sometimes surgery, with long-term eye and cancer follow-up.
How many clinical trials are available for Retinoblastoma?
RareWays currently indexes 83 clinical trials for Retinoblastoma, of which 8 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Retinoblastoma come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Retinoblastoma.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.